Source: SYS-CON MEDIA

Clontech: Clontech Laboratories, Inc. to Release a Highly Sensitive Kit for Human T-Cell Receptor Repertoire Analysis

MOUNTAIN VIEW, Calif., Jan. 20, 2016 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the upcoming launch of the SMARTer® Human TCR a/b Profiling Kit. This system leverages SMART® technology and employs a 5' RACE-like approach to capture complete V(D)J variable regions of TCR transcripts, enabling users to analyze T-cell receptor (TCR) diversity from human RNA samples or directly from cells.read more

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Kenneth Fong's photo - Founder & CEO of Clontech

Founder & CEO

Kenneth Fong

CEO Approval Rating

70/100

Read more